Literature DB >> 6966345

Immunological approaches to cancer treatment.

R W Baldwin.   

Abstract

Immunological approaches to cancer treatment are reviewed to consider the role of specifically sensitized effector cells as well as non-specific mechanisms. The induction of immunity by specific mechanisms is exemplified by the response to carcinogen induced animal tumours but this is contrasted with the lack of this type of response with naturally occurring animal tumours. These experimental findings are reviewed in relation to the clinical approaches to active immunotherapy. Regional immunotherapy, where bacterial adjuvants are administered so as to localize in tumour deposits is generally more effective than systemic immunotherapy. This is discussed in relation to the animal studies and these approaches are reviewed, particularly in connection with the treatment of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966345     DOI: 10.1007/BF02468641

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  20 in total

Review 1.  Induction of tumor-immune responses and their interaction with the developing tumor.

Authors:  R W Baldwin; R A Robins
Journal:  Contemp Top Mol Immunol       Date:  1977

Review 2.  BCG in tumor immunotherapy.

Authors:  R W Baldwin; M V Pimm
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

Review 3.  Immunotherapy from malignant disease.

Authors:  J E Goodnight; D L Morton
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

Review 4.  Antitumor activity of Corynebacterium parvum.

Authors:  L Milas; M T Scott
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Controlled trial of active immunotherapy in management of stage IIB malignant melanoma.

Authors:  M B McIllmurray; M J Embleton; W G Reeves; M J Langman; M Deane
Journal:  Br Med J       Date:  1977-02-26

Review 6.  Cell-mediated immunity to tumor cells.

Authors:  R B Herberman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

7.  Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

Authors:  B Zbar; I D Bernstein; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

8.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

Review 9.  Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors:  D Morton; F R Eilber; R A Malmgren; W C Wood
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

10.  Regional immunotherapy of lung cancer with intrapleural B.C.G.

Authors:  M F McKneally; C Maver; H W Kausel
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

View more
  1 in total

1.  Adjuvant therapy in colorectal cancer.

Authors:  A K House
Journal:  J R Soc Med       Date:  1984-06       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.